Special Issue: Traditional Chinese Medicine
| 1 Su SB, Lu A, Li S, Jia W.Evidence-based ZHENG: a traditional Chinese medicine syndrome.
2 Chen Z, Wang P.Clinical distribution and molecular basis of traditional Chinese medicine ZHENG in cancer.
3 Ling CQ. My view on traditional Chinese medicine etiology and pathogenesis of cancer.
4 Ling CQ.Cancerous toxin is the key pathogenic factor of malignant tumor.
5 Yue XQ. Towards better understanding the definition of cancerous toxin.
6 Wang XM, Zhang Q. Discussion on occurrence and development of tumor based on ‘cancerous toxin’.
7 Ling CQ. Problems in cancer treatment and major research of integrative medicine.
8 Liu YJ, Fang ZQ, Di RH, Xu LY. Statistical analysis of clinically reported syndromes differentiation of2492 PHC cases.
9 Yuan L, Zhang PT, Yang ZY. Study on
10 Sun DZ, Liu L, Jiao JP, Wei PK, Jiang LD, Xu L.Syndrome characteristics of traditional Chinese medicine: summary of a clinical survey in 767 patients with gastric cancer.
11 Yang ZJ, Zhang Y, Guo ZQ. Preliminary study on relationship between syndrome differentiation of esophageal cancer and changes of exfoliated cells of tongue coating.
12 Liang F, Sun J, Li Q, Li CH, Fan ZZ.Analysis of clinical syndromes in 47 patients with pancreatic cancer at late stage.
13 Chien TJ, Song YL, Lin CP, Hsu CH.The correlation of traditional Chinese medicine deficiency syndromes, cancer related fatigue, and quality of life in breast cancer patients.
14 Guo Y, Zou Y, Xu YF, Wang H, Li Y, Qian LY, Yang WH.Study on Chinese medicine syndrome of colorectal carcinoma in perioperative period.
15 Cheng RF, Wu ZL. Discussion of the pathogenesis theory of primary liver cancer: deficiency, depression, phlegm, blood stasis, toxin.
16 Zhang YH, Qin X, Xu J. Analysis of Chinese medical syndrome features of patients with primary liver cancer before and after transcatheter arterial chemoembolization.
17 Fang ZQ, Li YJ, Tang CL, Ma J, Guan DY, Chen DS. Analysis on characteristics of syndromes in2060 cases of primary hepatic cancer.
18 Zhang YM. Bo Liansong’s experience in treating large intestine cancer by supporting healthy qi and eliminating pathogenic facors.
19 Cheng CW, Kwok AO, Bian ZX, Tse DM.The quintessence of traditional Chinese medicine: syndrome and its distribution among advanced cancer patients with constipation.
20 Li F, Zhao C, Xia Z, Wang Y, Zhou X, Li GZ.Computer-assisted lip diagnosis on traditional Chinese medicine using multi-class support vector machines.
21 Yue XQ, Liu Q. Analysis of studies on pattern recognition of tongue image in traditional Chinese medicine by computer technology.
22 Pang B, Zhang D, Li N, Wang K.Computerized tongue diagnosis based on Bayesian networks.
23 Hu JQ, Zhao T, Xu GC, Wu L, Kou QA, Zhuang H, Li ZH, Su ML, Zhang GF. Assessment on the accuracy of four types of pulse by SM-1A TCM pulse detector.
24 Niu X, Yang XZ, Zhu QW, Li HY, Ma LX, Niu TL, Guo Z, Dong XY. Realization of the digitalization and quantification of key techniques of auxiliary diagnosis based on the four TCM diagnostic methods used in combination.
25 Wang YQ, Yan HX, Guo R, Li FF, Xia CM, Yan JJ, Xu ZX, Liu GP, Xu J.Study on intelligent syndrome differentiation in traditional Chinese medicine based on multiple information fusion methods.
26 Liu L, Xu L, Sun DZ, Wei PK. Establishment of a fuzzy mathematical model for syndrome differentiation of gastric cancer.
27 Li DT, Ling CQ, Zhu DZ. Study on the quantitative evaluation on the degree of TCM basic syndromes often encountered in patients with primary liver cancer.
28 Hou FG, Cen Y, Guan J, Zhu LY, Yin XL. Quantified diagnostic standard for large intestinal cancer of spleen qi deficiency syndrome.
29 Luo HG, Han Z, Li JX, Ma R, Yuan Q, Song XJ, Huang XM. Study on syndrome law of gastric precancerous lesion in traditional Chinese medicine.
30 Su W, Xu ZY, Wang ZQ, Xu JT.Objectified study on tongue images of patients with lung cancer of different syndromes.
31 Deng WZ, Yue XQ, Liu Q, Gao JD, Ren RZ, Ling CQ. Comparative study on normal tongue manifestation in patients with primary liver cancer and healthy adults.
32 Hu KW, Wang F, Cao Y, He XL, Zuo MH, Chen WQ. Risk factors of traditional Chinese medical syndromes in moderate and advanced lung cancer patients with concurrent fungal pneumonia.
33 He SL, Dong JC, Guan YH. Study on glucose metabolic rate in non-small cell lung cancer patients with blood stasis syndrome and non-blood stasis syndrome.
34 Mi YY, Hu YJ, Zhou MZ. Study of relationship between level of serum selenium and syndrome differentiation and typing of traditional Chinese medicine in lung cancer.
35 Mi YY, Zhou MZ. Probe into internal relation between classification of the differentiation-syndrome in traditional Chinese medicine and serum copper and zinc in lung cancer.
36 Lin SC, Huang ML, Liu SJ, Huang YF, Chiang SC, Chen MF.Severity of Yin deficiency syndrome and autonomic nervous system function in cancer patients.
37 Lin SC, Chen MF.Increased yin-deficient symptoms and aggravated autonomic nervous system function in patients with metastatic cancer.
38 Yan XS, Li HM, Peng YQ. The relevant research on neoplastic marker of lung cancer and TCM differentiation of syndromes.
39 Yu LJ, Chen Q, Mo CW, Wang J. Study on the correlation between TCM syndrome differentiation and tumor markers in colorectal cancer.
40 Lech A, Daneva T, Pashova S, Gagov H, Crayton R, Kukwa W, Czarnecka AM, Szczylik C.Ovarian cancer as a genetic disease.
41 Wang HQ, Zhang Z, Zhao YP, Li J, Chen K. Expression of HSP70 and P53 in malignant tumor tissues and its relationship to heat syndrome of TCM.
42 Chen W, Ouyang XN, Lin QC. Study on the relationship between vascular endothelial growth factor and syndrome type of traditional Chinese medicine in patients with gastric carcinoma.
43 Luo XQ, Xu YM, Tang Y. Pathological basis of qi-deficiency and blood stasis syndrome in patients with non-small cell lung cancer viewing from tumor metastasis related factors.
44 Pan ZQ, Fang ZQ, Lu WL, Liang C, Wu ZH, Liu XM, Hou L, Zhang H, Zhuo SY, Liao MJ, Gao BF. Differentially expressed genes in adrenal gland of H22 liver cancer mice with different syndromes and in different stages.
45 Cui TJ, Chen YQ, Dai YM. Study of the correlation between the colorectal cancer Chinese medicine syndrome typesand (excision repair cross-complementing 1, ERCC1) gene polymorphisms.
46 Zhang J, Zhan Z, Wu J, Zhang C, Yang Y, Tong S, Wang R, Yang X, Dong W.Association among lifestyle, clinical examination, polymorphisms in CDH1 gene and traditional Chinese medicine syndrome differentiation of gastric cancer.
47 Hood L, Heath JR, Phelps ME, Lin B.System biology and new technologies enable predictive and preventative medicine. Science. 2004; 306(5696): 640-643.
48 Dai J, Sun S, Cao H, Zheng N, Wang W, Gou X, Su S, Zhang Y.Applications of new technologies and new methods in ZHENG differentiation.
49 Gao S, Chen LY, Wang P, Liu LM, Chen Z.MicroRNA expression in salivary supernatant of patients with pancreatic cancer and its relationship with ZHENG.
50 Liu Z, Yu Z, Ouyang X, Du J, Lan X, Zhao M.Applied research on serum protein fingerprints for prediction of Qi deficiency syndrome and phlegm and blood stasis in patients with non-small cell lung cancer.
51 Yang SF, Qiu SP, Liu QH. Observation of serum protein fingerprinting in primary liver cancer patients of different Chinese medical syndromes before and after interventional treatment.
52 Yang SF. Differentially expressed proteins in serum among different Chinese medical syndrome types of primary liver cancer in the perioperative period of interventional treatment.
53 Chen QL, Lu YY, Zhang GB, Song YN, Zhou QM, Zhang H, Zhang W, Tang XS, Su SB.Characteristic analysis from excessive to deficient syndromes in hepatocarcinoma underlying miRNA array data.
54 Pan ZQ, Fang ZQ, Lu WL, Liang C, Wu ZH, Liu XM, Gao BF. Differentially expressed genes of MAPK signal pathway in different symptoms and signs about H22 tumour mice on base of adrenal gland gene-chip.
55 Pan ZQ, Fang ZQ, Lu WL, Liang C, Wu ZH, Liu XM, Gao BF. Gene expression of Smad signal pathway in adrenal gland in H22 tumor-bearing mice with different syndromes.
56 Dai HY, Wang P, Feng LY, Liu LM, Meng ZQ, Zhu XY, Wang K, Hua YQ, Mao YX, Chen LY, Chen Z.The molecular mechanisms of traditional Chinese medicine ZHENG syndromes on pancreatic tumor growth.
57 Chen Z, Liu LM, He YB. Characteristics of W256 tumor growth and liver metastasis in rats with blood stasis syndrome.
58 Yin JH, Shi WD, Zhu XY, Chen Z, Liu LM.Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.
59 Du J, Sun Y, Wang XF, Lu YY, Zhou QM, Su SB.Establishment of an experimental breast cancer ZHENG model and curative effect evaluation of Zuo-Jin Wan.
60 Yang XB, Long SQ, Wu WY, Deng H, Pan ZQ, He WF, Zhou YS, Liao GY. Treating primary liver cancer patients by Pi-strengthening and Qi-regulating method: univariate and multivariate analyses of their prognoses.
61 Chen XZ, Tian HQ, Huang XQ, Liang GW, Huang ZQ. Effect of Ganji formula on blood stasis in patients with advanced liver cancer.
62 Wang P, Huang WX, Liu LM.Overview of clinical and experimental study on Spleen-nourishing and Qi-regulating therapy for liver cancer.
63 Chen XP, Zhang YP, Zhu XR. Clinical study on effects of Tiepi fengdou granule/capsule combined with chemotherapy and/or radiotherapy in treating lung cancer with Qi-yin asthenia syndrome.
64 Qin ZF, Wei PK, Li J. Effect of kanglaite injection combined with Chinese drug therapy according to syndrome differentiation on quality of life and immune function in patients with advanced lung cancer.
65 Tao L, Zhu YJ, Lu XM, Gu Y, Zhao AG, Zheng J, Fu CG, Yang JK. Clinical study on survival benefit for elderly patients with resected stage II or III colorectal cancer based on traditional Chinese medicine syndrome differentiation and treatment.
66 Lang WJ. Analysis of the clinical application of Aidi injection in treating cancer.
67 Xue Q, Zhao JF. The clinical application of Shenling Baizhu decoction in the treatment of malignant tumor.
68 Wang P, Chen Z.Traditional Chinese medicine ZHENG and Omics convergence: a systems approach to post-genomics medicine in a global world. OMICS. 2013; 17(9): 451-459.
|||Ming-min Xu, Pei Guo, Qing-yu Ma, Xuan Zhou, Yu-long Wei, Lu Wang, Yue Chen, Yu Guo. Can acupuncture enhance therapeutic effectiveness of antidepressants and reduce adverse drug reactions in patients with depression? A systematic review and meta-analysis. Journal of Integrative Medicine, 2022, 20(4): 305-320.|
|||Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384.|
|||Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364.|
|||Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192.|
|||Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212.|
|||Ting-ting Lu, Cun-cun Lu, Mei-xuan Li, Li-xin Ke, Hui Cai, Ke-hu Yang. Reporting and methodological quality of meta-analyses of acupuncture for patients with migraine: A methodological investigation with evidence map. Journal of Integrative Medicine, 2022, 20(3): 213-220.|
|||Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134.|
|||Witoo Dilokthornsakul, Ramanya Kosiyaporn, Rattanamanee Wuttipongwaragon, Piyameth Dilokthornsakul. Potential effects of propolis and honey in COVID-19 prevention and treatment: A systematic review of in silico and clinical studies. Journal of Integrative Medicine, 2022, 20(2): 114-125.|
|||Jun-peng Yao, Li-ping Chen, Xian-jun Xiao, Ting-hui Hou, Si-yuan Zhou, Ming-min Xu, Kai Wang, Yu-jun Hou, Lin Zhang, Ying Li. Effectiveness and safety of acupuncture for treating functional constipation: An overview of systematic reviews. Journal of Integrative Medicine, 2022, 20(1): 13-25.|
|||Jing Hong, Xiao-wan Xu, Jing Yang, Jing Zheng, Shu-mei Dai, Ju Zhou, Qing-mei Zhang, Yi Ruan, Chang-quan Ling. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey. Journal of Integrative Medicine, 2022, 20(1): 34-44.|
|||Ofer Baranovitch, Meirav Wolff-Bar, Meora Feinmesser, Chen Sade-Zaltz, Ilan Tsarfaty, Victoria Neiman. Searching for the emotional roots of breast cancer: A cross-disciplinary analysis integrating psychology, Chinese medicine, and oncology biomarkers. Journal of Integrative Medicine, 2022, 20(1): 57-64.|
|||Jia-jia Li, Qing Liang, Guang-chun Sun. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. Journal of Integrative Medicine, 2021, 19(6): 469-477.|
|||Gai Ran, Xi-lin Feng, Yi-lin Xie, Qing-yun Zheng, Peng-peng Guo, Ming Yang, Ying-lu Feng, Chen Ling, Li-qing Zhu, Chen Zhong. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy. Journal of Integrative Medicine, 2021, 19(6): 515-525.|
|||Yi Yuan, Rui-Ting Wang, Jun Xia, Hui-Juan Cao. Interventions for preventing influenza: an overview of Cochrane systematic reviews and a Bayesian network meta-analysis. Journal of Integrative Medicine, 2021, 19(6): 503-514.|
|||Mao-xing Pan, Chui-yang Zheng, Yuan-jun Deng, Kai-rui Tang, Huan Nie, Ji-qian Xie, Dong-dong Liu, Gui-fang Tu, Qin-he Yang, Yu-pei Zhang. Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease . Journal of Integrative Medicine, 2021, 19(5): 428-438.|